MedPath

Hypertension Screening and Treatment Program

Completed
Conditions
Hypertension
Registration Number
NCT00007592
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.

Detailed Description

Primary Hypothesis: A variety of clinical questions of major importance can be addressed using clinical data routinely obtained in the VA Hypertension Screening and Treatment Program. For example, treatment of mild hypertension reduces the risk of strokes and heart attacks.

Secondary Hypothesis: Target organ damage occurs despite blood pressure control.

Intervention: Chlorthalidone, furosemide, hydrochlorothiazide, metolazone, indapamide, amiloride, spironolactone, triamterene, atenolol, metoprolol, nadolol, pindolol, propranolol, timolol, acebutolol, penbutolol, clonidine, guanethidine, methydopa, prazosin, guanadrel, labetalol, reserpine, guanfacine, hydralazine, minoxidil, captopril, enalapril, lisinopril, diltiazem, nifedipine, verapamil, nicardipine, dyazide, maxzide, pargyline, terazosin, other anti-hypertensives.

Primary Outcomes: Blood Pressure and Target Organ Damage

Study Abstract: Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.

This demonstration project provides for central collection of a standard set of clinical data for patients at some of the Hypertension Screening and Treatment Program clinics, thereby setting up a national data base on the treatment of hypertension. The primary objective of this project is to demonstrate the value of establishing this type of database. The database is being used to estimate the average annual cost of different antihypertensive regimens, to determine the cost-efficacy of different therapies and the least expensive effective therapy and to address some major unanswered clinical questions that require large populations and long-term patient care data. There are currently 13 medical centers participating.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

Vamc - Jackson

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Vamc - Pittsburgh

πŸ‡ΊπŸ‡Έ

Pittsburgh, Pennsylvania, United States

Vamc - Iowa City

πŸ‡ΊπŸ‡Έ

Iowa City, Iowa, United States

Vamc - Memphis

πŸ‡ΊπŸ‡Έ

Memphis, Tennessee, United States

Vamc - Richmond

πŸ‡ΊπŸ‡Έ

Richmond, Virginia, United States

Vamc - Sepulveda

πŸ‡ΊπŸ‡Έ

Sepulveda, California, United States

Vamc - Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Vamc - Indianapolis

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

Vamc - Dayton

πŸ‡ΊπŸ‡Έ

Dayton, Ohio, United States

Vamc - San Juan, Pr

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Vamc - Philadelphia

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Vamc - Washington, Dc

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Β© Copyright 2025. All Rights Reserved by MedPath